Login
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc.

nrxpharma.com

What Do They Do?

Provides therapy services to patients and develops medicines for central nervous system disorders including depression, chronic pain and PTSD.

How Do They Make Money?

Commercial insurers, Medicare and patients pay for outpatient behavioral-health, interventional psychiatry and pain-management care. Procedures are charged when performed, while therapy and medication management are charged session by session; payment follows within one year of service.

revenue
SegmentShareRevenue
Procedures
Usage-based

30%
Therapy
Usage-based

70%

Who Are Their Customers?

Patients receive outpatient behavioral-health, interventional psychiatry and pain-management services, with bills paid by commercial insurers, Medicare and individual patients.

Do Revenues Turn Into Profits?

No. It lost $28.6M in FY2025.

Operating income, FY2025
−1324% of revenue
▲ +12% (Loss) vs FY2024 (−$18.5M)
Net income, FY2025
−2336% of revenue
▼ −14% (Loss) vs FY2024 (−$25.1M)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +500%
vs $200K in Q3 FY2025
Net income
▲ +63% (Loss)
vs −$5.9M in Q3 FY2025
Therapy share of revenue vs 62.8% in Q3 FY2025

Adds patient-care services The older report describes a clinical-stage drug developer; the latest also describes HOPE as a medical-services company providing interventional psychiatric care through clinics.

Adds a generic ketamine path The older report discusses ketamine as a candidate for treating severe bipolar depression; the latest describes a separate generic-approval route for preservative-free ketamine alongside an NDA route for depression treatment.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support